HEALTH
<i> Times Staff and Wire Reports</i>
Glaxo-Wellcome Merger Passes U.S. Scrutiny: Glaxo’s $14.3-billion deal with rival British drug maker Wellcome received antitrust clearance from the Federal Trade Commission. The new Glaxo-Wellcome will be the world’s largest pharmaceutical company, with annual sales of $12.7 billion and a 5.3% market share. The FTC’s approval is conditional on Glaxo divesting itself of a migraine drug it has under development.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
